[4]. Halliday BP, Wassall R, Lota AS, et al. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED‑HF): an open‑label, pilot, randomised trial [J]. Lancet, ...
[4].Halliday BP, Wassall R, Lota AS, et al. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED‑HF): an open‑label, pilot, randomised trial [J]. Lancet, 2019, 393(10166): 61‑73....
3. Halliday BP, Wassall R,Lota AS et al. Withdrawal of pharmacological treatment for heart failure inpatients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot,randomised trial. The Lancet 2019;393:61-73. 4. Tanabe K, Sakam...
[11]. Brouse S, et al. 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024 Apr 16;83(15):1444-1488. [12]. Maddox TM, Januzzi JL...